Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria

Clinical Genetics

Volumn 75, Issue 2, 2009, Pages 169-174

  Sharman, R ^a   Sullivan, K ^a   Young, R ^a   Mcgill, J ^b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Adolescents; BRIEF; Dietary compliance; Executive function; Phenylalanine: Tyrosine ratio; Phenylketonuria

Indexed keywords

BIOCHEMICAL MARKER; METHYLPHENIDATE; PHENYLALANINE; TYROSINE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BIOCHEMISTRY; BRAIN FUNCTION; CHILD BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; HUMAN; LEARNING DISORDER; NEUROLOGIC DISEASE; PATIENT COMPLIANCE; PHENYLKETONURIA; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SCHOOL CHILD; SIBLING; WORKING MEMORY;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; COGNITION; HUMANS; NEUROPSYCHOLOGICAL TESTS; PHENYLALANINE; PHENYLKETONURIAS; PSYCHOMOTOR PERFORMANCE; TYROSINE;

EID: 58849142126     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2008.01101.x     Document Type: Article

References (27)

1. Pitt D, Danks D. The natural history of untreated phenylketonuria over 20 years. J Paediatr Child Health 1991: 27: 189-190.
2. Welsh MC, Pennington BF, Ozonoff S, Rouse B, McCabe ERB. Neuropsychology of early treated phenylketonuria: Specific executive function deficits. Child Dev 1990: 61: 1697-1713.
3. Weglage J, Pietesch M, Funders B, Koch HG, Ullrich K. Deficits in selective attention processes in early treated children with phenylketonuria -result of impaired frontal lobe function? Eur J Pediatr 1996: 155: 200-204.
4. Smith ML, Klim P, Hanley WB. Executive function in school aged children with phenylketonuria. J Dev Phys Disabil 2000: 12: 317-332.
5. Brumm VL, Azen C, Moats RA et al. Neuropsychological outcome of subjects participating in the adult PKU collaborative study: A preliminary review. J Inherit Metab Dis 2004: 27: 549-566.
6. Diamond A, Prevor MB, Callender G, Druin DP. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr Soc ReI Child Dev 1997: 62 (4): i-iv.
7. Huijbregts SC, de Sonneville LM, van Spronsen FJ, Licht R, Sergeant JA. The neuropsychological profile of early and continuously treated phenylketonuria: Orienting, vigilance, and maintenance versus manipulation-functions of working memory. Neurosci Biobehav Rev 2002: 26 (6): 697-712.
8. Antshel KM, Waisbren SE. Timing is everything: Executive functions in children exposed to elevated levels of phenylalanine. Neuropsychology 2003: 17 (3): 458-468.
9. Arnold GL, Vladutiu CJ, Orlowski CC, Blakely EM, DeLuca J. Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria. J Inherit Metab Dis 2004: 27 (2): 137-143.
10. Leuizzi V, Pansini M, Sechi E et al. Executive function impairment in early-treated PKU subjects with normal mental development. J Inherit Metab Dis 2004: 27: 115-125.
11. Luciana M, Sullivan J, Nelson CA. Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria. Child Dev 2001: 72 (6): 1637-1653.
12. Lykkelund C, Nielsen JB, Lou HC et al. Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine. Eur J Pediatr 1988: 148: 238-245.
13. Smith ML, Hanley WB, Clarke JT et al. Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria. Arch Dis Child 1998: 78: 116-121.
14. Poustie VJ, Rutherford P. Tyrosine supplementation for phenylketonuria. Cochrane Database Syst Rev 1999: (3).
15. Koch R, Moats R, Guttler F, Guldberg P, Nelson M Jr. Blood-brain phenylalanine relationships in persons with phenylketonuria. Pediatrics 1990: 106 (5): 1093-1096.
16. Australian Society for Inborn Errors of Metabolism. The PKU handbook. Alexandra, Victoria: Human Genetic Society of Australia, 2005.
17. Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behaviour Rating Inventory of Executive Function, professional manual. Lutz, FL: Psychological Assessment Resources Inc, 2000.
18. Gioia GA, Isquith PK. Ecological assessment of executive function in traumatic brain injury. Dev Neuropsychol 2004: 25: 135-158.
19. Mangeot A, Armstrong K, Colvin AN, Yeates KO, Taylor HG. Long-term executive function deficits in children with traumatic brain injuries: assessment using the Behavior Rating Inventory of Executive Function (BRIEF). Child Neuropsychol 2002: 8: 271-284.
20. Mahone EM, Cirino PT, Cutting LE et al. Validity of the behavior rating inventory of executive function in children with ADHD and/or Tourette syndrome. Arch Clin Neuropsychol 2002: 17: 643-662.
21. Baron SI. Test review: Behaviour rating inventory of executive function. Child Neuropsychol 2000: 6: 235-238.
22. Gioia GA, Isquith PK, Kenworthy L, Barton RM. Profiles of everyday executive function in acquired and developmental disorders. Child Neuropsychol 2002: 8: 121-137.
23. Waisbren SE, Noel K, Fahrbach K et al. Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta-analysis. Mol Genet Metab 2007: 92: 63-70.
24. Huijbregts SC, de Sonneville LM, Licht R, van Spronsen FJ, Verkerk PH, Sergeant JA. Sustained attention and inhibition of cognitive interference in treated phenylketonuria: Associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia 2002: 40 (1): 7-15.
25. van Zutphen KH, Packman W, Sporri L et al. Executive functioning in children and adolescents with phenylketonuria. Clin Genet 2007: 72 (1): 13-18.
26. Bilginsoy C, Waiztman N, Leornard C, Ernst S. Living with phenylketonuria, perspectives of patients and their families. J Inherit Metab Dis 2005: 28 (5): 639-645.
27. MacDonald A. Diet and compliance in phenylketonuria. Eur J Pediatr 2000: 159 (Suppl. 2): 136-141.